Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 136 of the 140 references it cites were found in a registry or an index.

Specific Inhibition of HIF Activity: Can Peptides Lead the Way?

Open access

Abstract

Reduced oxygen availability (hypoxia) is a characteristic of many disorders including cancer. Central components of the systemic and cellular response to hypoxia are the Hypoxia Inducible Factors (HIFs), a small family of heterodimeric transcription factors that directly or indirectly regulate the expression of hundreds of genes, the products of which mediate adaptive changes in processes that include metabolism, erythropoiesis, and angiogenesis. The overexpression of HIFs has been linked to the pathogenesis and progression of cancer. Moreover, evidence from cellular and animal models have convincingly shown that targeting HIFs represents a valid approach to treat hypoxia-related disorders. However, targeting transcription factors with small molecules is a very demanding task and development of HIF inhibitors with specificity and therapeutic potential has largely remained an unattainable challenge. Another promising approach to inhibit HIFs is to use peptides modelled after HIF subunit domains known to be involved in protein–protein interactions that are critical for HIF function. Introduction of these peptides into cells can inhibit, through competition, the activity of endogenous HIFs in a sequence and, therefore also isoform, specific manner. This review summarizes the involvement of HIFs in cancer and the approaches for targeting them, with a special focus on the development of peptide HIF inhibitors and their prospects as highly-specific pharmacological agents.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers13030410

Cites

136 of 136 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Regulation of HIFα subunits and Hypoxia Inducible Factors (HIF) transcriptional activity. When oxygen is abundant, PHDs and FIH hydroxylate two proline and one asparagine residue inside the ODDD and C-TAD regions of HIFα, respectively. Prolyl-hydroxylation leads to pVHL-mediated ubiquitination of HIFα subunits and their destruction in the proteasome while asparaginyl hydroxylation also inhibits HIFα interaction with CBP/P300. When oxygen levels drop, hydroxylases become inactive and HIFα subunits are stabilized and transported into the nucleus with the help of multiple importins (Imp α, β, 4, and 7). ERK-mediated phosphorylation of HIFα subunits ensures their nuclear accumulation by abrogating the association of HIFα with exportin CRM1. Nuclear HIFα subunits form a functional complex with ARNT, which binds to HREs on DNA and coactivators, such as CBP/p300 to induce transcription of hypoxia-regulated genes.
Figure 1 Regulation of HIFα subunits and Hypoxia Inducible Factors (HIF) transcriptional activity. When oxygen is abundant, PHDs and FIH hydroxylate two proline and one asparagine residue inside the ODDD and C-TAD regions of HIFα, respectively. Prolyl-hydroxylation leads to pVHL-mediated ubiquitination of HIFα subunits and their destruction in the proteasome while asparaginyl hydroxylation also inhibits HIFα interaction with CBP/P300. When oxygen levels drop, hydroxylases become inactive and HIFα subunits are stabilized and transported into the nucleus with the help of multiple importins (Imp α, β, 4, and 7). ERK-mediated phosphorylation of HIFα subunits ensures their nuclear accumulation by abrogating the association of HIFα with exportin CRM1. Nuclear HIFα subunits form a functional complex with ARNT, which binds to HREs on DNA and coactivators, such as CBP/p300 to induce transcription of hypoxia-regulated genes.CC BY · PubMed Central
Figure 2 Peptide-mediated HIFα targeting. Peptides target the association of distinct HIF-1α domains (as indicated) with components of the hypoxia signaling or transcription machinery, such as ARNT, PHDs and CBP/P300 (activating peptides in green, inhibiting in red). Modification of HIF-1α by ERK and its phosphorylation-dependent nuclear interactions can also be inhibited by ERK Targeted Domain (ETD)-derived peptides.
Figure 2 Peptide-mediated HIFα targeting. Peptides target the association of distinct HIF-1α domains (as indicated) with components of the hypoxia signaling or transcription machinery, such as ARNT, PHDs and CBP/P300 (activating peptides in green, inhibiting in red). Modification of HIF-1α by ERK and its phosphorylation-dependent nuclear interactions can also be inhibited by ERK Targeted Domain (ETD)-derived peptides.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 140 references

Cited by

See all 21

Metadata

Authors
Mylonis, I., Chachami, G., & Simos, G.
Affiliations
University of Thessaly (GR)
Corresponding author
  • Mylonis, Ilias
  • Simos, George
Venue
Cancers
Publisher
MDPI AG
Published
2021-01-22
Volume
13
Issue
3
Pages
410
ISSN
2072-6694 (ISSN-L)
OpenAlex
W3123050006
Cited by
21
References
140
Citations by year
2025: 4 · 2024: 6 · 2023: 4 · 2022: 4 · 2021: 3
FWCI
0.51
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
Funders
Fondation Santé (5360)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
Keywords
hypoxia-inducible factor, HIF inhibitors, peptide inhibitors, protein-protein interaction, transcription factor targeting, angiogenesis, erythropoiesis, HIF-targeted therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Specific Inhibition of HIF Activity: Can Peptides Lead the Way? https://app.cochat.ai/papers/10.3390/cancers13030410
The paper
Mylonis, I., Chachami, G., & Simos, G. (2021). Specific Inhibition of HIF Activity: Can Peptides Lead the Way? Cancers. https://doi.org/10.3390/cancers13030410

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.